(19)
(11) EP 4 824 061 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24905034.5

(22) Date of filing: 13.12.2024
(51) International Patent Classification (IPC): 
C07D 471/04(2006.01)
A61P 25/04(2006.01)
C07D 401/06(2006.01)
 A61K 9/00(2006.01)
A61P 29/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 29/00; C07D 471/04; A61P 25/04; A61K 9/0014; A61K 47/10; A61K 9/06
(86) International application number:
PCT/US2024/060214
(87) International publication number:
WO 2025/129126 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 14.12.2023 US 202363610218 P

(71) Applicant: VM Therapeutics LLC
Fremont, CA 94538 (US)

(72) Inventors:
  • WU, Jay Jie-Qiang
    Fremont, California 94538 (US)
  • WANG, Ling
    Fremont, California 94538 (US)

(74) Representative: Cooley (UK) LLP 
22 Bishopsgate
London EC2N 4BQ
London EC2N 4BQ (GB)

   


(54) TOPICAL FORMULATIONS OF CALCIUM CHANNEL BLOCKERS